ArticleEvidence-based complementary and alternative medicine : eCAM2012
Development and Validation of an Instrument for Measuring Attitudes and Beliefs about Complementary and Alternative Medicine (CAM) Use among Cancer Patients.
Article in Evidence-based complementary and alternative medicine : eCAM, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 33 citations in OpenAlex.
- Development and Validation of a Brief Self-Report Scale to Measure Perceived Immune Vulnerability (PIV) in Cancer Population.Cancers · 2025Article
- Utilization Pattern of Acupuncture and Its Associated Predictors for Cancer Pain in South Korea: A Cross-Sectional Study.Diseases (Basel, Switzerland) · 2025Article
- Bedside counseling on complementary medicine as a new model in pediatric cancer care-protocol of the SiKOM multicenter prospective cohort study.Frontiers in pediatrics · 2025Article
- Feasibility of implementing acupuncture in medically underserved breast cancer survivors (FAB): A protocol.Contemporary clinical trials · 2024Article
- Predictors of herbal medicine use among cancer patients.Journal of cancer research and clinical oncology · 2023Article
- In reply to "could acupuncture be a treatment option for cancer patients with attitudinal barriers to pharmacological pain management?" by Kako, Kajiwara, and Kobayashi.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Fear of analgesic side effects predicts preference for acupuncture: a cross-sectional study of cancer patients with pain in the USA.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- What if Acupuncture Were Covered by Insurance for Pain Management? A Cross-Sectional Study of Cancer Patients at One Academic Center and 11 Community Hospitals.Pain medicine (Malden, Mass.) · 2019Article
- Evaluating Cancer Patients' Expectations and Barriers Toward Traditional Chinese Medicine Utilization in China: A Patient-Support Group-Based Cross-Sectional Survey.Integrative cancer therapies · 2018Article
- Barriers to Acupuncture Use Among Breast Cancer Survivors: A Cross-Sectional Analysis.Integrative cancer therapies · 2018Article
- Acupuncture versus medication for pain management: a cross-sectional study of breast cancer survivors.Acupuncture in medicine : journal of the British Medical Acupuncture Society · 2018Article
- Article
- Mixed Methods in CAM Research: A Systematic Review of Studies Published in 2012.Evidence-based complementary and alternative medicine : eCAM · 2013Review
- Patients' Expectations and Barriers Toward Reishi Mushroom Use in Cancer Care: A Cross-Sectional Survey.Integrative cancer therapiesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
Despite cancer patients' extensive use of complementary and alternative medicine (CAM), validated instruments to measure attitudes, and beliefs predictive of CAM use are lacking. We aimed at developing and validating an instrument, attitudes and beliefs about CAM (ABCAM). The 15-item instrument was developed using the theory of planned behavior (TPB) as a framework. The literature review, qualitative interviews, expert content review, and cognitive interviews were used to develop the instrument, which was then administered to 317 outpatient oncology patients. The ABCAM was best represented as a 3-factor structure: expected benefits, perceived barriers, and subjective norms related to CAM use by cancer patients. These domains had Eigenvalues of 4.79, 2.37, and 1.43, and together explained over 57.2% of the variance. The 4-item expected benefits, 7-item perceived barriers, and 4-item subjective norms domain scores, each had an acceptable internal consistency (Cronbach's alpha) of 0.91, 0.76, and 0.75, respectively. As expected, CAM users had higher expected benefits, lower perceived barriers, and more positive subjective norms (all P < 0.001) than those who did not use CAM. Our study provides the initial evidence that the ABCAM instrument produced reliable and valid scores that measured attitudes and beliefs related to CAM use among cancer patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.